Largest biotech companies in the United States by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 20 biotech companies in the United States ranked by net assets, at CHF 19.2B, ahead of Biogen (CHF 15.4B) and Amgen (CHF 7.3B). Figures as of 19 Nov 2026, 23:27 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Gilead SciencesCHF 19.2B
Median
CHF 1.4B
Combined market value
CHF 620.3B
Countries
1

Market values as of .

United States
All sectors
Biotech
CHF
Clear filters
Largest biotech companies in the United States by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareCHF 19.2BCHF 174.3BCHF 140.55 1.45% down 35% up United States
2BiogenBIIB · Health CareCHF 15.4BCHF 30.8BCHF 208.57 1.70% down 49% up United States
3AmgenAMGN · Health CareCHF 7.3BCHF 200.3BCHF 370.36 1.14% down 32% up United States
4ModernaMRNA · Health CareCHF 7.3BCHF 68.1BCHF 168.23 1.29% up 780% up United States
5Neurocrine BiosciencesNBIX · Health CareCHF 2.7BCHF 13.4BCHF 132.16 3.85% down 17% up United States
6VaxcytePCVX · Health CareCHF 2.3BCHF 7.8BCHF 49.25 0.27% down 23% up United States
7ExelixisEXEL · Health CareCHF 1.8BCHF 13.6BCHF 55.56 3.60% down 63% up United States
8Bio-TechneTECH · Health CareCHF 1.8BCHF 9.6BCHF 61.36 0.07% down 24% up United States
9RepligenRGEN · Health CareCHF 1.8BCHF 9.2BCHF 143.72 1.38% down 12% up United States
10Revolution MedicinesRVMD · Health CareCHF 1.4BCHF 29.1BCHF 134.56 0.24% down 129% up United States
11Kymera TherapeuticsKYMR · Health CareCHF 1.3BCHF 8.6BCHF 100.76 1.44% down 87% up United States
12Krystal BiotechKRYS · Health CareCHF 1BCHF 7.9BCHF 266.55 0.15% up 54% up United States
13ImmunovantIMVT · Health CareCHF 719.6MCHF 5.7BCHF 27.45 1.96% down 46% up United States
14CG OncologyCGON · Health CareCHF 635.2MCHF 6.2BCHF 69.12 2.38% up 97% up United States
15Twist BioscienceTWST · Health CareCHF 399.2MCHF 6.4BCHF 94.21 4.07% down 346% up United States
16Scholar Rock HoldingSRRK · Health CareCHF 207.2MCHF 5.2BCHF 42.51 4.94% up 26% up United States
17Adaptive BiotechnologiesADPT · Health CareCHF 184.7MCHF 3.8BCHF 23.67 1.44% down 74% up United States
18Kodiak SciencesKOD · Health CareCHF 132.8MCHF 5.4BCHF 82.63 0.09% up 399% up United States
19Halozyme TherapeuticsHALO · Health CareCHF 41.2MCHF 9BCHF 78.52 2.88% down 39% up United States
20ImmunityBioIBRX · Health Care-CHF 422.4MCHF 5.9BCHF 5.54 1.94% down 232% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8440 CHF).

Questions and answers

Which biotech companies in the United States rank first by net assets?

Gilead Sciences (CHF 19.2B), Biogen (CHF 15.4B) and Amgen (CHF 7.3B) are the top three of the 20 biotech companies in the United States ranked by net assets as of 19 Nov 2026, 23:27 UTC.

How many biotech companies in the United States are in this ranking?

20 are ranked by net assets.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by net assets have a combined market value of CHF 620.3B as of 19 Nov 2026, 23:27 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech companies in the United States by net assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.